Member Info for BuenaVista

@Bella, the Abzena contributor to that poster works at Abzena in Cambridge, UK, which seems to be a contract biologics R&D business.

https://abzena.com/about/locations/cambridge-uk/

What Pfizer has bought is a manufacturing plant in the US.

😭👶

Starting a thread quoting Myles McNulty is obsessional?

Did I say I was complaining?

Yes anybody could do that, except, Emoji Boy, Myles would be playing with a trading pot in addition to a huge Avacta holding and, if caught out, would be out with a huge profit.

Https://x.com/MylesMcNulty/status/1952730470631809029

@2:56 PM · Aug 5, 2025: "The SP has had a 5 day consolidation period following the run from 30p placing to tagging 60p last Wednesday. Now it looks like it's gearing up for the next leg up. This pattern will play out many dozens of times over the next year or two (essentially, until AVCT is acquired!) - an aggressive run up, a pullback to a higher low, a short conidiation period, and then the next aggressive leg up. Simple to see this pattern already building in the 4 week chart."

There's a man who can see the opportunity to trade.

Starting with £100,000 worth of 30p shares (333,333 shares from a modest outlay for a HNWI) and bouncing between 55p to sell and 48p to buy (a modest difference) that would be changed into:

£183,333.15 and 381,944 shares after 1 cycle

£210,069.20 and 437,644 shares after 2 cycles

£240,704.20 and 501,467 shares after 3 cycles

£275,806.85 and 574,597 shares after 4 cycles

£316,028.35 and 658,392 shares after 5 cycles

Just saying

President Camembert

They will issue an RNS to confirm completion of the Coris sale (due in August). That's news.

For other imminent news, see HurstBot's posting history.

Well go back and read my first post.

(In short: the totals of buys and sells are meaningless.)

So you are saying that if you buy shares at a price below the midprice, then it is really a sell?

But those aren't true data are they. They're just trades above or below the midprice point.

We need another Xcreation from Myles. Yesterday's didn't quite do it.😂

I think GSA's price is around 50p

/irony

Lol @Be4C citing https://www.tandfonline.com/doi/full/10.1517/17425247.3.3.311

That is a REVIEW from 2006 of PRE-2006 literature. What happened to that dream?

Stick to your deodorants.

"Aptamers not a competitor for Pre|cision"

Exactly

Pathetic. You really think your small oligonucleotide Optimer binders used in deodorant products are a competitor to Avacta's targetted anticancer drugs? No wonder you're more invested over there! Look down the back of your sofa, you mght find enough to buy another few thousand more Aptamer shares. 150p down to a ha'penny in a straight run is some feat!

Well Be4C, maybe you'd like to enlightened us as to why Aptamer (small oligonucleotides) may be a competitor for our pre|CISION platform...

Not a competitor in any sense.

That's good news then!